Axsome Therapeutics (AXSM) - Management Comments

Axsome Therapeutics (AXSM) – Management Comments

Apr 26, 2021 06:02 AM Axsome Therapeutics (AXSM) Reports FDA Acceptance and Priority Review of NDA for AXS-05 for Treatment of Major Depressive Disorder
Dec 31, 2020 06:33 AM Axsome Therapeutics (AXSM) Begins ACCORD Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
Dec 31, 2020 06:01 AM
Dec 8, 2020 06:28 AM
Sep 24, 2020 06:02 AM
Sep 21, 2020 07:04 AM
Sep 14, 2020 06:03 AM
Aug 5, 2020 07:18 AM
Jul 13, 2020 07:02 AM
Jun 26, 2020 07:01 AM
May 29, 2020 07:05 AM
Apr 27, 2020 06:05 AM
Apr 6, 2020 06:13 AM
Mar 30, 2020 06:01 AM
Mar 20, 2020 07:02 AM
Mar 5, 2020 07:06 AM
Feb 20, 2020 07:19 AM
Jan 22, 2020 07:06 AM
Jan 13, 2020 06:05 AM
Dec 16, 2019 06:02 AM
Dec 3, 2019 06:05 AM
Oct 21, 2019 07:02 AM
Oct 16, 2019 07:02 AM
Oct 2, 2019 08:47 AM
Sep 5, 2019 07:14 AM
Jun 24, 2019 07:06 AM
May 6, 2019 06:31 AM
Mar 4, 2019 07:02 AM
Feb 6, 2019 07:09 AM
Jan 30, 2019 07:00 AM
Jan 7, 2019 06:01 AM
Dec 10, 2018 07:03 AM
Nov 14, 2018 07:03 AM
Oct 17, 2018 07:02 AM
Oct 16, 2018 07:03 AM
Oct 11, 2018 07:05 AM
Apr 19, 2018 07:05 AM
Feb 26, 2018 07:02 AM
Jan 9, 2018 07:03 AM
Dec 14, 2017 07:26 AM
Nov 28, 2017 07:07 AM
Sep 7, 2017 07:09 AM
Jul 25, 2017 07:10 AM
Jul 17, 2017 07:04 AM
Jul 6, 2017 07:01 AM
May 8, 2017 07:15 AM
Mar 15, 2016 07:27 AM